Role of decay-accelerating factor in regulating survival of human cervical cancer cells

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 1, 2011, Pages 81-87

  Gao, Ling Juan ^a   Ding, Lan ^b   Guo, Shu Yu ^c   Cai, You Qun ^a   Su, Ya Juan ^c   Gong, Hui ^a   Liu, Yun ^a   Chen, Chen ^a   Gu, Ping Qing ^a  

^a Nanjing Maternity and Child Health Care Hospital   (China)

^b FUDAN UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Decay accelerating factor (DAF); Human cervical cancer cell (ME180); Small interference RNA (siRNA)

Indexed keywords

COMPLEMENT COMPONENT C3; DECAY ACCELERATING FACTOR; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; TUMOR CELL DESTRUCTION; UTERINE CERVIX CANCER;

ANTIGENS, CD55; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; COMPLEMENT C3-C5 CONVERTASES; DOWN-REGULATION; FEMALE; HUMANS; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 78751623216     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0862-3     Document Type: Article

References (16)

1. S Andersson AC Hellstr ZP Ren, et al. 2006 The carcinogenic role of oncogenic HPV and p53 gene mutation in cervical adenocarcinomas Med Oncol 23 113 119 1:CAS:528:DC%2BD28XktVOntLc%3D 10.1385/MO:23:1:113 16645236 (Pubitemid 43787124)
2. M Arora R Arora SC Tiwari, et al. 2000 Expression of complement regulatory proteins in diffuse proliferative glomerulonephritis Lupus 9 127 131 1:CAS:528:DC%2BD3cXjt1Cktb0%3D 10.1191/096120300678828154 10787010
3. L Bjorge J Hakulinen T Wahlstrom, et al. 1997 Complement-regulatory proteins in ovarian malignancies Int J Cancer 70 14 25 1:STN:280: DyaK2s7jvVSmuw%3D%3D 10.1002/(SICI)1097-0215(19970106)70:1<14::AID-IJC3>3. 0.CO;2-9 8985085 (Pubitemid 27059700)
4. FX Bosch S Sanjose 2003 Human papillomavirus and cervical cancer-burden and assessment of causality J Natl Cancer Inst Monogr 31 3 13 12807939
5. X Castellsague M Diaz S Sanjose, et al. 2006 Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention J Natl Cancer Inst 98 303 315 10.1093/jnci/djj067 16507827 (Pubitemid 43338210)
6. DS Cole BP Morgan 2003 Beyond lysis: how complement influences cell fate Clin Sci 104 455 466 1:CAS:528:DC%2BD3sXjtFKlsLk%3D 10.1042/CS20020362 12580763 (Pubitemid 36628141)
7. VI García FY Atisha PY Richaud, et al. 2006 Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia Lupus 15 600 605 10.1177/0961203306071916 (Pubitemid 44661748)
8. BL His JS Hunt JP Atkinson, et al. 1991 Differential expression of complement regulatory proteins on subpopulations of human trophoblast cells J Reprod Immunol 19 209 223 10.1016/0165-0378(91)90036-P
9. CH Holmes KL Simpson SD Wainwright, et al. 1990 Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy J Immunol 144 3099 3105 1:CAS:528:DyaK3cXitleksrs%3D 1691227
10. A Jemal R Siegel E Ward, et al. 2006 Cancer statistics J Clin 56 106 130
11. T Kiso M Mizuno J Nasu, et al. 2002 Enhanced expression of decay-accelerating factor and CD59/homologous restriction factor 20 in intestinal metaplasia, gastric adenomas and intestinal-type gastric carcinomas but not in diffuse-type carcinomas Histopathology 40 339 347 1:STN:280:DC%2BD383gvFGrsA%3D%3D 10.1046/j.1365-2559.2002.01350.x 11943018 (Pubitemid 34595584)
12. L Li I Spendlove J Morgan, et al. 2001 CD55 is over-expressed in the tumour environment Br J Cancer 84 80 86 1:CAS:528:DC%2BD3MXpvVWmsg%3D%3D 10.1054/bjoc.2000.1570 11139317 (Pubitemid 32102508)
13. DM Parkin F Bray J Ferlay, et al. 2001 Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 153 156 1:CAS:528:DC%2BD3MXntVGlu78%3D 10.1002/ijc.1440 11668491 (Pubitemid 32911406)
14. PY Richaud RB Pérez ME Carrillo, et al. 2003 Deficiency of red cell bound CD55 and CD59 in patients with systemic lupus erythematosus Immunol Lett 88 95 99 10.1016/S0165-2478(03)00066-X (Pubitemid 36859970)
15. BJ Van MM Van BA Hart, et al. 2005 Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation J Immunol 174 2353 2365
16. S Zell N Geis R Rutz, et al. 2007 Down-regulation of CD55 and CD46 expression bu anti-sense phosphorothioate oligonucleotides (S-ODNs) sensitizes tumour cells to complement attack Clin Exp Immunol 150 576 584 1:CAS:528:DC%2BD1cXitVyjtA%3D%3D 10.1111/j.1365-2249.2007.03507.x 17903221 (Pubitemid 350098731)